HC006

DRUG3 trials

Sponsors

HC Biopharma Inc.

Conditions

Advanced CancerAdvanced Solid TumorAdvanced Solid Tumor Cancer

Phase 1

A Study of HC006 in Subjects With Advanced Solid Tumors

RecruitingNCT06304571

HC Biopharma Inc.Advanced Solid Tumor

Start: 2024-02-27End: 2026-07-16Target: 76Updated: 2025-05-06

Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors

RecruitingNCT06963814

HC Biopharma Inc.Advanced Cancer

Start: 2025-07-04End: 2027-05-30Target: 252Updated: 2025-07-17

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

RecruitingNCT07477743

HC Biopharma Inc.Advanced Solid Tumor Cancer

Start: 2026-03-17End: 2028-03-31Target: 331Updated: 2026-03-17